维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

19篇 您的检索式：作者名="Shaughnessy JD Jr"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1 显示文摘	Shaughnessy JD Jr Zhan F Burington BE	2007	Blood2007，109，6：	1
	2	Proteasome inhibitors and bone disease显示文摘	Qiang YW Heuck CJ Shaughnessy JD Jr		0，，03：	1
	3	Seven-year median time to progression with thalidomide for smoldering myeloma:Partial response identifies subset requiring earlier salvage therapy for symptomatic disease显示文摘	Barlogie B Van Rhee F Shaughnessy JD Jr	2008	Blood2008，112，：	1
	4	Multiple myeloma 显示文摘	Anderson KC Shaughnessy JD Jr Barlogie B	2002	Hematology Am Soc Hematol Educ Program2002，，：	1
	5	Overview of bio-logical database mapping services for interoperation between dif-ferent 'omics' datasets显示文摘	Chavan SS Shaughnessy JD Jr Edmondson RD		0，，06：	1
	6	Wnt3a signaling within bone inhibits multiple myeloma bone disease and tu- mor growth显示文摘	Qiang YW Shaughnessy Jr JD Yaccoby S	2008	Blood2008，112，2：	1
	7	A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1显示文摘	Shaughnessy JD Jr Zhan F Burington BE	2007	Blood2007，109，6：	1
	8	Superior re- sults of Total Therapy 3 (2003-33) in gene expression profi- ling-defined low-risk multiple myeloma confirmed in subse- quent trial 2006-66 with VRD maintenance显示文摘	Nair B van Rhee F Shaughnessy JD Jr	2010	Blood2010，115，21：	1
	9	A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1 显示文摘	Shaughnessy JD Jr Zhan F Burington BE	2007	Blood2007，109，6：	1
	10	Multiple myeloma显示文摘	Anderson KC Shaughnessy JD Jr Barlogie B	2002	Hematology2002，1，：	1
	11	Complete remission in multiple myeloma examined as time-dependent variable in terms of both onset and duration in Total Therapy protocols显示文摘	Hoering A Crowley J Shaughnessy JD Jr	2009	Blood2009，114，：	1
	12	Pharmacogenomics of hortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMIM, as novel high-risk feature in myeloma treated with Total Therapy 3 显示文摘	Shaughnessy JD Jr Qu P Usmani S	2011	Blood2011，118，13：	1
	13	High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis显示文摘	Brenne AT Fagerli UM Shaughnessy JD Jr	2009	Eur J Haematol2009，82，5：	1
	14	Seven-year median time to progression with thalidomide for smoldering myeloma: partial response identifies subset requiring earlier salvage therapy for symptomatic disease显示文摘	Barloge B van Rhee F Shaughnessy JD Jr et ol	2008	Blood2008，112，：	1
	15	First thalidomide clinical trial in multiple myeloma: a decade显示文摘	van Rhee F Dhodapkar M Shaughnessy JD Jr	2008	Blood2008，112，4：	1
	16	Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growth显示文摘	Qiang YW Shaughnessy JD Jr Yaccoby S	2008	Blood2008，112，2：	1
	17	Complete remission in multiple myeloma examined as time-dependent variable in terms of both onset and duration in Total Therapy protocols 显示文摘	Hoering A Crowley J Shaughnessy JD Jr	2009	Blood2009，114，7：	1
	18	A validated gene expression model of high-risk multiple myeloma is defined byderegulated expression of genes mapping to chromosome 1 显示文摘	Shaughnessy JD Jr Zhan F Burington BE	2007	Blood2007，109，：	1
	19	A Validated validated Gene gene Expression expression Model model of Highhigh-Risk risk Multiple multiple Myeloma myeloma is Defined defined By by Deregulated deregulated Expression expression of Genes genes Mapping mapping to Chromosome chromosome 1显示文摘	Shaughnessy JD Jr Zhan F Burington B E	2007	Blood2007，109，6：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费